Jul 13, · Anecdotally, many doctors avoid prescribing spironolactone to patients with a history of breast cancer or at high risk of breast cancer since published reports expressed concern that the drug could increase the risk of breast cancers and other cancers in humans. 8 9 10 However, other studies have shown no increased risk and overall, studies in this area Cited by: We failed to find a positive association between spironolactone exposure and breast cancer in comparison with exposure to other drugs (aROR = 95% CI ) or pseudo aldosterone antagonists (amiloride, triamterene) ( ). Similar trends were found after exclusion of drug competitors and/or reports from health virginities.xyz by: 1.
A recent study provided reassurance that prescribing spironolactone to treat androgenic alopecia among patients who previously had breast cancer is likely safe. According to the findings, this therapy was not associated with an increased risk for breast cancer recurrence among survivors. Mar 23, · "With respect to breast, uterus, ovarian and cervical cancer, there is no evidence of increased risk with spironolactone or furosemide use" Another study, investigating prostate cancer risk, found similar results: "In this study, spironolactone use was associated with a lower incidence of prostate cancer, the most common cancer in men in the UK.".
Jun 22, · Spironolactone was not associated with breast cancer recurrence, according to study results presented at the American Academy of Dermatology’s Virtual Meeting Experience (AAD VMX) , held online from June 12 to 14, Author: Emily Pond. Oct 13, · Spironolactone is widely used to treat heart failure, hypertension and liver disease with increased usage in recent years. Spironolactone has endocrine effects that could influence cancer risks and historical reports suggest possible links with increased risk of certain types of virginities.xyz by: